Anders Pommer Vallentin
Overview
Explore the profile of Anders Pommer Vallentin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study
Kristensen D, Ovlisen A, Jakobsen L, Severinsen M, Hannig L, Starklint J, et al.
Blood Adv
. 2024 May;
8(16):4478-4485.
PMID: 38758071
Previous studies have suggested that metformin has beneficial effects beyond its glucose-lowering properties, particularly in terms of its potential as an antineoplastic and cancer-preventive agent. In this study, we aimed...
2.
Heftdal L, Hamm S, Perez-Alos L, Madsen J, Almagro Armenteros J, Fogh K, et al.
Eur J Haematol
. 2023 May;
111(2):229-239.
PMID: 37151174
Objectives: Initial responses to coronavirus disease 2019 vaccination are impaired in patients with hematological malignancies. We investigated immune responses after three or four doses of BNT162b2 in patients with myeloid...
3.
Kristensen D, Kisbye Ovlisen A, Jakobsen L, Severinsen M, Hannig L, Starklint J, et al.
Blood Adv
. 2023 Mar;
7(14):3450-3457.
PMID: 36877642
Previous studies have indicated a possible cancer-protective effect of statins in solid cancers; however, this has never been investigated in myeloproliferative neoplasms (MPNs). We aimed to investigate the association between...
4.
Lauritsen T, Norgaard J, Gronbaek K, Vallentin A, Ahmad S, Hannig L, et al.
Clin Epidemiol
. 2021 Jun;
13:439-451.
PMID: 34163252
Background: The Danish Myelodysplastic Syndromes Database (DMDSD) comprises nearly all patients diagnosed with myelodysplastic syndromes (MDS) in Denmark since 2010. The DMDSD has not yet been used for epidemiological research...